/PRNewswire/ Recursion (NASDAQ: RXRX), the clinical-stage biotechnology company industrializing drug discovery by decoding biology, today announced its.
/PRNewswire/ Recursion (NASDAQ: RXRX), the clinical-stage biotechnology company industrializing drug discovery by decoding biology, today announced its.
Roche and its Genentech subsidiary have committed up to $12 billion to Recursion in return for using its Recursion Operating System (OS) to advance therapies in 40 programs that include “key areas” of neuroscience and an undisclosed oncology indication.
SOUTH SAN FRANCISCO (dpa-AFX) - Biotechnology company Recursion (RXRX) announced Tuesday a collaboration with Roche holding AG (ROG, RHHBY) and Genentech, a member of the Roche Group, to advance